First Wave BioPharma Files US and PCT Patent Applications for Niclosamide in Long-Haul COVID-19

First Wave BioPharma, Inc. announced the continued enhancement of the intellectual property portfolio governing niclosamide as a treatment for COVID-19-related gastrointestinal infections.